Fidji Simo, OpenAI’s AGI chief, has stepped down from her full-time role due to a severe chronic illness and will transition to a part-time advisory position.
OpenAI’s chief futurist, Joshua Achiam, announced his departure from the company on Tuesday after nearly nine years, according to a note to staff obtained by WIRED.
A new artificial intelligence-driven workflow, dubbed an autonomous AI co-scientist, has been developed to accelerate the discovery of next-generation inhibitors for the epidermal growth factor receptor (EGFR), specifically targeting the C797S mutation that confers resistance to osimertinib in non-small cell lung cancer (NSCLC).
Policy analyst Al Vigier argues that while the strategy promises to boost Canadian AI adoption from 12 percent to 60 percent by 2034, the government has been quietly purchasing American systems, notably from Palantir Technologies, without public disclosure.